Related Experiment Video
Updated: May 24, 2026
Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging
Published on: June 21, 2011
Progress and application of intelligent nanomedicine in urinary system tumors
Yingming Xiao1, Lei Zhong1, Jinpeng Liu1
1Department of Urology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.
Abstract:
Urinary system tumors include malignancies of the bladder, kidney, and prostate, and present considerable challenges in diagnosis and treatment. The conventional therapeutic approaches against urinary tumors are limited by the lack of targeted drug delivery and significant adverse effects, thereby necessitating novel solutions. Intelligent nanomedicine has emerged as a promising therapeutic alternative for cancer in recent years, and uses nanoscale materials to overcome the inherent biological barriers of tumors, and enhance diagnostic and therapeutic accuracy. In this review, we have explored the recent advances and applications of intelligent nanomedicine for the diagnosis, imaging, and treatment of urinary tumors. The principles of nanomedicine design pertaining to drug encapsulation, targeting and controlled release have been discussed, with emphasis on the strategies for overcoming renal clearance and tumor heterogeneity. Furthermore, the therapeutic applications of intelligent nanomedicine, its advantages over traditional chemotherapy, and the challenges currently facing clinical translation of nanomedicine, such as safety, regulation and scalability, have also been reviewed. Finally, we have assessed the potential of intelligent nanomedicine in the management of urinary system tumors, emphasizing emerging trends such as personalized nanomedicine and combination therapies. This comprehensive review underscores the substantial contributions of nanomedicine to the field of oncology and offers a promising outlook for more effective and precise treatment strategies for urinary system tumors.
Insights
Intelligent nanomedicine offers a promising approach for diagnosing and treating urinary system tumors. This review explores its applications, advantages over traditional methods, and future potential in oncology.
Area of Science:
- Oncology
- Nanotechnology
- Urology
Background:
- Urinary system tumors (bladder, kidney, prostate) pose significant diagnostic and treatment challenges.
- Conventional therapies for urinary tumors lack targeted drug delivery and cause adverse effects.
- Intelligent nanomedicine utilizes nanoscale materials to overcome tumor barriers and improve accuracy.
Purpose of the Study:
- To review recent advances in intelligent nanomedicine for urinary tumor diagnosis, imaging, and treatment.
- To discuss nanomedicine design principles for drug delivery, targeting, and controlled release.
- To assess nanomedicine's potential and challenges in clinical translation for urinary cancers.
Main Methods:
- Exploration of recent literature on intelligent nanomedicine applications in urinary oncology.
- Discussion of strategies to overcome renal clearance and tumor heterogeneity.
- Review of therapeutic applications, advantages, and clinical translation challenges.
Main Results:
- Intelligent nanomedicine enhances diagnostic and therapeutic accuracy for urinary tumors.
- Nanomedicine strategies address challenges like renal clearance and tumor heterogeneity.
- Emerging trends include personalized nanomedicine and combination therapies.
Conclusions:
- Intelligent nanomedicine shows substantial contributions to urinary cancer management.
- It offers a promising outlook for more effective and precise treatment strategies.
- Further research is needed to address safety, regulation, and scalability for clinical use.
